rs1055138

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1

The NM_207352.4(CYP4V2):​c.64C>G​(p.Leu22Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.482 in 1,587,696 control chromosomes in the GnomAD database, including 186,194 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.46 ( 16288 hom., cov: 34)
Exomes 𝑓: 0.48 ( 169906 hom. )

Consequence

CYP4V2
NM_207352.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts P:1B:15

Conservation

PhyloP100: -0.996

Publications

45 publications found
Variant links:
Genes affected
CYP4V2 (HGNC:23198): (cytochrome P450 family 4 subfamily V member 2) This gene encodes a member of the cytochrome P450 hemethiolate protein superfamily which are involved in oxidizing various substrates in the metabolic pathway. It is implicated in the metabolism of fatty acid precursors into n-3 polyunsaturated fatty acids. Mutations in this gene result in Bietti crystalline corneoretinal dystrophy. [provided by RefSeq, Jul 2008]
CYP4V2 Gene-Disease associations (from GenCC):
  • Bietti crystalline corneoretinal dystrophy
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Illumina, Orphanet, Labcorp Genetics (formerly Invitae), G2P, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 24 curated pathogenic missense variants (we use a threshold of 10). The gene has 7 curated benign missense variants. Gene score misZ: -0.12103 (below the threshold of 3.09). Trascript score misZ: -0.14191 (below the threshold of 3.09). GenCC associations: The gene is linked to Bietti crystalline corneoretinal dystrophy.
BP4
Computational evidence support a benign effect (MetaRNN=3.741501E-5).
BP6
Variant 4-186191887-C-G is Benign according to our data. Variant chr4-186191887-C-G is described in ClinVar as Benign. ClinVar VariationId is 39267.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.501 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP4V2NM_207352.4 linkc.64C>G p.Leu22Val missense_variant Exon 1 of 11 ENST00000378802.5 NP_997235.3 Q6ZWL3-1
CYP4V2XM_005262935.5 linkc.64C>G p.Leu22Val missense_variant Exon 1 of 11 XP_005262992.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP4V2ENST00000378802.5 linkc.64C>G p.Leu22Val missense_variant Exon 1 of 11 1 NM_207352.4 ENSP00000368079.4 Q6ZWL3-1

Frequencies

GnomAD3 genomes
AF:
0.459
AC:
69750
AN:
151928
Hom.:
16272
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.427
Gnomad AMI
AF:
0.361
Gnomad AMR
AF:
0.423
Gnomad ASJ
AF:
0.456
Gnomad EAS
AF:
0.283
Gnomad SAS
AF:
0.398
Gnomad FIN
AF:
0.460
Gnomad MID
AF:
0.433
Gnomad NFE
AF:
0.506
Gnomad OTH
AF:
0.460
GnomAD2 exomes
AF:
0.444
AC:
89568
AN:
201924
AF XY:
0.447
show subpopulations
Gnomad AFR exome
AF:
0.424
Gnomad AMR exome
AF:
0.387
Gnomad ASJ exome
AF:
0.466
Gnomad EAS exome
AF:
0.272
Gnomad FIN exome
AF:
0.454
Gnomad NFE exome
AF:
0.505
Gnomad OTH exome
AF:
0.467
GnomAD4 exome
AF:
0.484
AC:
694802
AN:
1435650
Hom.:
169906
Cov.:
75
AF XY:
0.482
AC XY:
343795
AN XY:
712832
show subpopulations
African (AFR)
AF:
0.425
AC:
14045
AN:
33024
American (AMR)
AF:
0.393
AC:
16606
AN:
42232
Ashkenazi Jewish (ASJ)
AF:
0.468
AC:
12040
AN:
25734
East Asian (EAS)
AF:
0.284
AC:
10951
AN:
38572
South Asian (SAS)
AF:
0.405
AC:
33857
AN:
83504
European-Finnish (FIN)
AF:
0.462
AC:
20446
AN:
44278
Middle Eastern (MID)
AF:
0.448
AC:
2449
AN:
5464
European-Non Finnish (NFE)
AF:
0.504
AC:
556326
AN:
1103380
Other (OTH)
AF:
0.472
AC:
28082
AN:
59462
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
22614
45228
67843
90457
113071
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16020
32040
48060
64080
80100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.459
AC:
69805
AN:
152046
Hom.:
16288
Cov.:
34
AF XY:
0.453
AC XY:
33718
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.427
AC:
17740
AN:
41512
American (AMR)
AF:
0.423
AC:
6465
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.456
AC:
1583
AN:
3470
East Asian (EAS)
AF:
0.282
AC:
1449
AN:
5130
South Asian (SAS)
AF:
0.398
AC:
1920
AN:
4828
European-Finnish (FIN)
AF:
0.460
AC:
4876
AN:
10598
Middle Eastern (MID)
AF:
0.428
AC:
125
AN:
292
European-Non Finnish (NFE)
AF:
0.506
AC:
34344
AN:
67908
Other (OTH)
AF:
0.463
AC:
977
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
2000
4000
6001
8001
10001
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
646
1292
1938
2584
3230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.489
Hom.:
5601
Bravo
AF:
0.453
TwinsUK
AF:
0.489
AC:
1815
ALSPAC
AF:
0.503
AC:
1940
ESP6500AA
AF:
0.413
AC:
1786
ESP6500EA
AF:
0.489
AC:
4174
ExAC
AF:
0.421
AC:
49477
Asia WGS
AF:
0.354
AC:
1229
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Pathogenic:1Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Bietti crystalline corneoretinal dystrophy Pathogenic:1Benign:5
Nov 20, 2020
Molecular Genetics, Royal Melbourne Hospital
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Population allele frequency is 45% (101,504/227,310 alleles; gnomAD v2.0.2). Based on the classification scheme RMH ACMG Guidelines v1.1.1, this variant is classified as Benign. Following criteria met: BA1 -

Apr 12, 2012
GeneReviews
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:curation

- -

May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 25, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Department of Ophthalmology and Visual Sciences Kyoto University
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Mar 14, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Corneal dystrophy Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Retinal dystrophy Benign:1
Oct 01, 2023
Dept Of Ophthalmology, Nagoya University
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.064
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
0.15
DANN
Benign
0.52
DEOGEN2
Benign
0.050
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.0042
N
LIST_S2
Benign
0.12
T
MetaRNN
Benign
0.000037
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
-0.90
N
PhyloP100
-1.0
PrimateAI
Uncertain
0.51
T
PROVEAN
Benign
-0.19
N
REVEL
Benign
0.027
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.014
MPC
0.11
ClinPred
0.0066
T
GERP RS
0.68
PromoterAI
-0.059
Neutral
Varity_R
0.039
gMVP
0.50
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1055138; hg19: chr4-187113041; COSMIC: COSV66505124; COSMIC: COSV66505124; API